Lowe Carol P
Director · ARW, EME
As of 2026-09-16, Lowe Carol P has 15 Form 4 transactions on record across 2 companies — 8 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | EME | Sale | 950 @ $844.50 | $802K | −5.2% of holding | 17,278 | Form 4 |
14 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | ARW | Award / grant | 164 | 4,773 | Form 4 |
| 2026-06-04 | EME | Award / grant | 304 | 18,228 | Form 4 |
| 2026-05-15 | ARW | Award / grant | 168 | 4,610 | Form 4 |
| 2026-05-12 | ARW | Award / grant | 968 | 8,004 | Form 4 |
| 2026-02-13 | ARW | Award / grant | 224 | 4,442 | Form 4 |
| 2026-01-30 | EME | Award / grant | 1 | 17,924 | Form 4 |
| 2025-11-14 | ARW | Award / grant | 324 | 4,218 | Form 4 |
| 2025-08-15 | ARW | Award / grant | 283 | 3,894 | Form 4 |
| 2025-06-05 | EME | Award / grant | 485 | 17,923 | Form 4 |
| 2025-05-15 | ARW | Award / grant | 290 | 3,611 | Form 4 |
| 2025-05-06 | ARW | Award / grant | 1,694 | 7,036 | Form 4 |
| 2025-04-30 | EME | Award / grant | 1 | 17,438 | Form 4 |
| 2025-02-14 | ARW | Award / grant | 321 | 3,321 | Form 4 |
| 2025-01-31 | EME | Award / grant | 1 | 17,437 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.